Lewis L. Smith

4.9k total citations
107 papers, 3.8k citations indexed

About

Lewis L. Smith is a scholar working on Surgery, Molecular Biology and Pharmacology. According to data from OpenAlex, Lewis L. Smith has authored 107 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 37 papers in Molecular Biology and 28 papers in Pharmacology. Recurrent topics in Lewis L. Smith's work include Paraquat toxicity studies and treatments (37 papers), Estrogen and related hormone effects (22 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Lewis L. Smith is often cited by papers focused on Paraquat toxicity studies and treatments (37 papers), Estrogen and related hormone effects (22 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Lewis L. Smith collaborates with scholars based in United Kingdom, United States and Sweden. Lewis L. Smith's co-authors include I. Wyatt, Michael S. Rose, Gerald M. Cohen, Edward A. Lock, Ian N.H. White, Peter L. Keeling, Francesco De Matteis, Elizabeth A. Martin, Adrian Davies and W. McLean Provan and has published in prestigious journals such as Nature, PLoS ONE and Environmental Health Perspectives.

In The Last Decade

Lewis L. Smith

107 papers receiving 3.6k citations

Peers

Countries citing papers authored by Lewis L. Smith

Since Specialization

Citations

This map shows the geographic impact of Lewis L. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis L. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis L. Smith more than expected).

Fields of papers citing papers by Lewis L. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis L. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis L. Smith. The network helps show where Lewis L. Smith may publish in the future.

Co-authorship network of co-authors of Lewis L. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis L. Smith. A scholar is included among the top collaborators of Lewis L. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis L. Smith. Lewis L. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice 2016 ·PLoS ONE ·Richard J. Smeyne, Charles B. Breckenridge, Melissa J. Beck, Yun Jiao, Mark T. Butt, Jeffrey C. Wolf, (unknown), Daniel J. Minnema, Nicholas C. Sturgess, Kim Z. Travis, (unknown), Lewis L. Smith, Philip A. Botham	78
2	Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice 2013 ·NeuroToxicology ·Charles B. Breckenridge, Nicholas C. Sturgess, Mark T. Butt, Jeffrey C. Wolf, (unknown), Melissa J. Beck, James M. Mathews, Merrill O. Tisdel, Daniel J. Minnema, Kim Z. Travis, (unknown), Philip A. Botham, Lewis L. Smith	36
3	Tamoxifen mutagenesis and carcinogenesis in livers of lambda/lacI transgenic rats: selective influence of phenobarbital promotion 2001 ·Cancer Letters ·J.A. Styles, Reginald Davies, (unknown), Joseph Walker, Ian N.H. White, Lewis L. Smith	12
4	Chemoprevention of Breast Cancer by Tamoxifen: Risks and Opportunities 2000 ·Critical Reviews in Toxicology ·Lewis L. Smith, Karen Brown, P. Carthew, (unknown), Elizabeth A. Martin, J.A. Styles, Ian N.H. White	70
5	The Effect of a Low-Protein Diet and Dietary Supplementation of Threonine on Tyrosine and 2-(2-Nitro-4-trifluoromethylbenzoyl) cyclohexane-1,3-dione-Induced Corneal Lesions, the Extent of Tyrosinemia, and the Activity of Enzymes Involved in Tyrosine Catabolism in the Rat 1998 ·Toxicology and Applied Pharmacology ·Edward A. Lock, (unknown), Martin K. Ellis, Mervyn Robinson, W. McLean Provan, Lewis L. Smith	19
6	Mutational specificity: Mutational spectra of tamoxifen-induced mutations in the livers oflacl transgenic rats 1996 ·Environmental and Molecular Mutagenesis ·Reginald Davies, Victor Oreffo, S. C. Bayliss, (unknown), Kathryn S. Lilley, Ian N.H. White, Lewis L. Smith, J.A. Styles	12
7	Tissue Distribution of 2-(2-Nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione (NTBC): Effect on Enzymes Involved in Tyrosine Catabolism and Relevance to Ocular Toxicity in the Rat 1996 ·Toxicology and Applied Pharmacology ·Edward A. Lock, (unknown), Martin K. Ellis, W. McLean Provan, Mervyn Robinson, Lewis L. Smith, Michael P. Prisbylla, Linda Mutter	41
8	³²P-Postlabelled DNA adducts in liver obtained from women treated with tamoxifen 1995 ·Carcinogenesis ·Elizabeth A. Martin, Kim J. Rich, Ian N.H. White, K L Woods, (unknown), Lewis L. Smith	74
9	Methylene chloride: an inhalation study to investigate toxicity in the mouse lung using morphological, biochemical and Clara cell culture techniques 1994 ·Toxicology ·John R. Foster, T. Green, Lewis L. Smith, (unknown), I. Wyatt	23
10	A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes 1994 ·Carcinogenesis ·Chang Kee Lim, Zhi‐Xin Yuan, John H. Lamb, Ian N.H. White, Francesco De Matteis, Lewis L. Smith	92
11	Genotoxicity of tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s 1994 ·Carcinogenesis ·J.A. Styles, Adrian Davies, C.K. Lim, Federico De Matteis, Lesley A. Stanley, Ian N.H. White, Zhi‐Xin Yuan, Lewis L. Smith	101
12	High performance liquid chromatography of tamoxifen and metabolites in plasma and tissues 1993 ·Biomedical Chromatography ·C.K. Lim, (unknown), Zhi‐Xin Yuan, Lewis L. Smith	19
13	Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells 1992 ·Carcinogenesis ·(unknown), Francesco De Matteis, Adrian Davies, Lewis L. Smith, C. Crofton-Sleigh, Stanley Venitt, Alan Hewer, David H. Phillips	207
14	Molecular features necessary for the uptake of diamines and related compounds by the polyamine receptor of rat lung slices 1991 ·Biochemical Pharmacology ·Mary C. O’Sullivan, Bernard T. Golding, Lewis L. Smith, I. Wyatt	26
15	The importance of epithelial uptake systems in lung toxicity. 1990 ·Environmental Health Perspectives ·Lewis L. Smith, (unknown), I. Wyatt, Gerald M. Cohen	24
16	Lipid Peroxidation Is Not a Major Factor Involved in the Edema Formation in Perfused Lungs 1987 ·European Surgical Research ·Bo Risberg, Lewis L. Smith, M. H. Schoenberg, Mamoun Younes	3
17	Inability of a human lung tumour cell line (A549) to detect chemically induced organ-specific toxicity to the lung 1987 ·Toxicology in Vitro ·Katherine O’Brien, Lewis L. Smith, Gerald M. Cohen	7
18	Prevention of Edema Formation in the Perfused Lung Preparation by Oxygen Radical Scavengers 1985 ·European Surgical Research ·Bo Risberg, Lewis L. Smith, (unknown)	11
19	Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Martin Griffin, Lewis L. Smith, (unknown)	65
20	The accumulation of paraquat by the lung and the relevance of this to the treatment of paraquat poisoning 1975 ·Toxicology and Applied Pharmacology ·Michael S. Rose, Lewis L. Smith, I. Wyatt	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact